Monitoring the expression profiles of integrins and adhesion/growth- regulatory galectins in adamantinomatous craniopharyngiomas: Their ability to regulate tumor adhesiveness to surrounding tissue and their contribution to prognosis

Neurosurgery

Volumn 56, Issue 4, 2005, Pages 763-775

  Lefranc, Florence ^a   Mijatovic, Tatjana ^b   Decaestecker, Christine ^b   Kaltner, Herbert ^c   André, Sabine ^c   Brotchi, Jacques ^a   Salmon, Isabelle ^a   Gabius, Hans Joachim ^c   Kiss, Robert ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adamantinomatous craniopharyngiomas; Complementary deoxyribonucleic acid microarray; Computer assisted microscopy; Galectins; Immunohistochemistry; Integrins; Recurrence

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COMPLEMENTARY DNA; FIBRONECTIN; GALECTIN; GALECTIN 4; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LAMININ; MESSENGER RNA; TENASCIN; THROMBOSPONDIN; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN;

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CRANIOPHARYNGIOMA; DNA MICROARRAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

CAROTID ARTERY, INTERNAL; CELL ADHESION; CRANIOPHARYNGIOMA; GALECTINS; GENE EXPRESSION PROFILING; HUMANS; INTEGRINS; OPTIC CHIASM; PITUITARY GLAND; PITUITARY NEOPLASMS; PROGNOSIS; RNA, MESSENGER;

EID: 16844381878     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000156788.44397.B4     Document Type: Article

References (68)

1. Adamson TE, Wiestler OD, Kleihues P, Yaşargil MG: Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73:12-17, 1990.
2. Andre S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius HJ: Galectins-1 and -3 and their ligands in tumor biology: Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity. J Cancer Res Clin Oncol 125:461-474, 1999.
3. Andre S, Pieters RJ, Vrasidas I, Kaltner H, Kuwabara I, Liu FT, Liskamp RM, Gabius HJ: Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters and cell surface glycoconjugates. Chembiochem 2:822-330, 2001.
4. Boudreau NJ, Jones PL: Extracellular matrix and integrin signaling: The shape of things to come. Biochem J 339:481-488, 1999.
5. Brada M, Thomas DG: Craniopharyngioma revisited. Int J Radiat Oncol Biol Phys 27:471-475, 1993.
6. Brewer CF: Binding and cross-linking properties of galectins. Biochim Biophys Acta 1572:263-273, 2002.
7. Broggi G, Franzini A, Cajola L, Pluchino F: Cell kinetic investigations in Craniopharyngioma: Preliminary results and considerations. Pediatr Neurosurg 21:21-23, 1994.
8. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius HJ, Kiss R: Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 61:585-596, 2002.
9. Camby I, Belot N, Rorive S, Lefranc F, Maurage CA, Lahm H, Kaltner H, Hadari Y, Ruchoux MM, Brotchi J, Zick Y, Salmon I, Gabius HJ, Kiss R: Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 11:12-26, 2001.
10. Camby I, Nagy N, Lopes MB, Schafer BW, Maurage CA, Ruchoux MM, Murmann P, Pochet R, Heizmann CW, Brotchi J, Salmon I, Kiss R, Decaestecker C: Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol 9:825-843, 1999.
11. Cooper DN: Galectinomics: Finding themes in complexity. Biochim Biophys Acta 1572:209-231, 2002.
12. Chiu ML, Parry DA, Feldman SR, Klapper DG, O'Keefe EJ: An adherens junction protein is a member of the family of lactose-binding lectins. J Biol Chem 269:31770-31776, 1994.
13. Crotty TB, Scheithauer BW, Young WF Jr, Davis DH, Shaw EG, Miller GM, Burger PC: Papillary craniopharyngioma: A clinicopathological study of 48 cases. J Neurosurg 83:206-214, 1995.
14. Danguy A, Camby I, Kiss R: Galectins and cancer. Biochim Biophys Acta 1572:285-293, 2002.
15. Duo D, Gasverde S, Benech F, Zenga F, Giordana MT: MIB-1 immunoreactivity in craniopharyngiomas: A clinico-pathological analysis. Clin Neuropathol 22:229-234, 2003.
16. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M: Surgical treatment of craniopharyngiomas: Experience with 168 patients. J Neurosurg 90:237-250, 1999.
17. Farnoud MR, Farhadian F, Samuel JL, Derome P, Peillon F, Li JY: Fibronectin isoforms are differentially expressed in normal and adenomatous human anterior pituitaries. Int J Cancer 61:27-34, 1995.
18. Gabius HJ: Influence of type of linkage and spacer on the interaction of β-galactoside-binding proteins with immobilized affinity ligands. Anal Biochem 189:91-94, 1990.
19. Gabius HJ: Animal lectins. Eur J Biochem 243:543-576, 1997.
20. Gabius HJ: Biological information transfer beyond the genetic code: The sugar code. Naturwissenschaften 87:108-121, 2000.
21. Gabius HJ: Glycohistochemistry: The why and how of detection and localization of endogenous lectins. Anat Histol Embryol 30:3-31, 2001.
22. Gabius HJ: Probing the cons and pros of lectin-induced immunomodulation: Case studies for the mistletoe lectin and galectin-1. Biochimie 83:659-666, 2001.
23. Giancotti FG, Ruoslahti E: Integrin signaling. Science 285:1028-1032, 1999.
24. Habrand JL, Ganry O, Couanet D, Rouxel V, Levy-Piedbois C, Pierre-Kahn A, Kalifa C: The role of radiation therapy in the management of craniopharyngiomas: A 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 44:255-263, 1999.
25. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y: Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 113:2385-2397, 2000.
26. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, Kodama T, Aburatani H: Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61:889-895, 2001.
27. Horacek MJ, Thompson JC, Dada MO, Terracio L: The extracellular matrix component laminin, fibronectin, and, collagen IV are present among the epithelial cells forming Rathke's pouch. Acta Anat 147:69-74, 1993.
28. Huflejt ME, Jordan ET, Gitt MA, Barondes SH, Leffler H: Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells. J Biol Chem 272:14294-14303, 1997.
29. Hughes RC: Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1473:172-185, 1999.
30. Isaac MA, Hahn SS, Kim JA, Bogart JA, Chung CT: Management of craniopharyngiomas. Cancer J 7:516-520, 2001.
31. Ivaska J, Heino J: Adhesion receptors and cell invasion: Mechanisms of integrin-guided degradation of extracellular matrix. Cell Mol Life Sci 57: 16-24, 2000.
32. Janzer RC, Burger PC, Giangaspero F, Paulus W: Craniopharyngioma, in Kleihues P, Cavenee WK (eds): Tumors of the Sellar Regions: World Health Organization Classification of Tumors-Pathology and Genetics: Tumours of the Nervous System. Lyon, IARC Press, 2000, pp 243-248.
33. Kaltner H, Stierstorfer B: Animal lectins as cell adhesion molecules. Acta Anat (Basel) 161:162-179, 1998.
34. Kim SK, Wang KC, Shin SH, Choe G, Chi JG, Cho BK: Radical excision of pediatric craniopharyngioma: Recurrence pattern and prognostic factors. Childs Nerv Syst 17:531-537, 2001.
35. Kopitz J, Andre S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu FT, Cantz M, Heck AJ, Gabius HJ: Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 22:6277-6288, 2003.
36. Kopitz J, von Reitzenstein C, Andre S, Kaltner H, Uhl J, Ehemann V, Cantz M, Gabius HJ: Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 276:35917-35923, 2001.
37. Kopitz J, von Reitzenstein C, Burchert M, Cantz M, Gabius HJ: Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem 273:11205-11211, 1998.
38. Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL, Hsu DK, Liu FT: Galectin-7 (PIG1: p53-induced gene 1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome C release. J Biol Chem 277:3487-3497, 2002.
39. Lahm H, Andre S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ: Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127:375-386, 2001.
40. Lefranc F, Chevalier C, Vinchon M, Dhellemmes P, Schuring MP, Kaltner H, Brotchi J, Ruchoux MM, Gabius HJ, Salmon I, Kiss R: Characterization of the levels of expression of retinoic acid receptors, galectin-3, macrophage migration inhibitory factor and p53 in 51 adamantinomatous craniopharyngiomas. J Neurosurg 98:145-153, 2003.
41. Levy Y, Arbel-Goren R, Hadari YR, Eshhar S, Ronen D, Elhanany E, Geiger B, Zick Y: Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem 276:31285-31295, 2001.
42. Liszczak T, Richardson EP, Phillips JP, Jacobson S, Kornblith PL: Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas. Acta Neuropathol (Berl) 43:191-203, 1978.
43. Liu FT, Patterson RJ, Wang JL: Intracellular functions of galectins. Biochim Biophys Acta 1572:263-273, 2002.
44. Lubansu A, Ruchoux MM, Brotchi J, Salmon I, Kiss R, Lefranc F: Cathepsin B, D and K expression in adamantinomatous craniopharyngiomas relates to their levels of differentiation as determined by the patterns of retinoic acid receptor expression. Histopathology 43:563-572, 2003.
45. Martin KH, Slack JK, Boerner SA, Martin CC, Parsons JT: Integrin connections map: To infinity and beyond. Science 296:1652-1653, 2002.
46. Moisan S, Demers M, Mercier J, Magnaldo T, Potworowski EF, St-Pierre Y: Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia 17:751-759, 2003.
47. Moiseeva EP, Javed Q, Spring EL, De Bono DP: Galectin-1 is involved in vascular smooth muscle cell proliferation. Cardiovasc Res 45:493-502, 2000.
48. Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H, Hadari Y, Van Ham P, Yeaton P, Pector JC, Zick Y, Salmon I, Danguy A, Kiss R, Gabius HJ: Galectin-8 expression decreases in cancer as compared to normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration. Gut 50:392-401, 2002.
49. Nagy N, Legendre H, Engels O, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius HJ, Salmon I, Kiss R: Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 97:1849-1858, 2003.
50. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A: Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156:899-909, 2000.
51. Nishi T, Kuratsu J, Takeshima H, Saito Y, Kochi M, Ushio Y: Prognostic significance of the MIB-1 labeling index for patients with craniopharyngiomas. Int J Mol Med 3:157-161, 1999.
52. Plow EF, Haas TA, Zhang L, Lofrus J, Smith JW: Ligand binding to integrins. J Biol Chem 275:21785-21788, 2000.
53. Rabinovich GA, Rubinstein N, Toscano M: Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta 1572:274-284, 2002.
54. Raghavan R, Dickey WT Jr, Margraf LR, White CL III, Coimbra C, Hynan LS, Rushing EJ: Proliferative activity in craniopharyngiomas: Clinicopathological correlations in adults and children. Surg Neurol 54:241-248, 2000.
55. - leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death. Leukemia 16:840-845, 2002.
56. Reuter G, Gabius HJ: Eukaryotic glycosylation: Whim of nature or multipurpose tool? Cell Mol Life Sci 55:368-422, 1999.
57. Rutka JT: Craniopharyngioma. J Neurosurg 97:1-2, 2002.
58. Sarubi JC, Bei H, Adams EF, Boson WL, Friedman E, Brandao K, Kalapothakis E, Miranda D, Valle FL, Sarquis MS, De Marco L: Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsα and Gc2α genes. Neurosci Lett 310:5-8, 2001.
59. Scott RM, Hetelekidis S, Barnes PD, Goumnerova L, Tarbell NJ: Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma: A 20-year experience. Pediatr Neurosurg 21[Suppl 1]:75-81, 1994.
60. Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S: Craniopharyngiomas of adamantinomatous type harbor β-catenin gene mutations. Am J Pathol 161:1997-2001, 2002.
61. Siebert HC, Andre S, Lu SY, Frank M, Kaltner H, van Kuik JA, Korchagina EY, Bovin N, Tajkhorshid E, Kaptein R, Vliegenthart JF, von der Lieth CW, Jimenez-Barbero J, Kopitz J, Gabius HJ: Unique conformer selection of the human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. Biochemistry 42:14762-14773, 2003.
62. Thapar K, Stefaneanu L, Kovacs K, Scheithauer BW, Lloyd RV, Muller PJ, Laws ER Jr: Estrogen receptor gene expression in craniopharyngiomas: An in situ hybridization study. Neurosurgery 35:1012-1017, 1994.
63. Timmons PM, Colnot C, Cail I, Poirier F, Magnaldo T: Expression of galectin-7 during epithelial development coincides with the onset of stratification. Int J Dev Biol 43:229-235, 1999.
64. Van Effenterre R, Boch AL: Craniopharyngioma in adults and children: A study of 122 surgical cases. J Neurosurg 97:3-11, 2002.
65. Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW: Angiogenesis in patients with craniopharyngiomas: Correlation with treatment and outcome. Cancer 94:738-745, 2002.
66. Wasano K, Hirakawa Y: Two domains of rat galectin-4 bind to distinct structures of the intercellular borders of colorectal epithelia. J Histochem Cytochem 47:75-82, 1999.
67. Wu AM, Wu JH, Tsai MS, Liu JH, Andre S, Wasano K, Kaltner H, Gabius HJ: Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochem J 367:653-664, 2002.
68. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A: Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 277:6852-45857, 2002.